NCT01581411View on ClinicalTrials.gov

Intra-arterial Thrombolysis for Severe Recent Central Retinal Vein Occlusion

PHASE1CompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Central Retinal Vein Occlusion
Interventions
DRUG

Tissue Plasminogen Activator

Intra-ophthalmic artery injection of 2 mg t-PA over 10 minutes followed by 10 mg t-PA over 2 hours

Trial Locations (1)

10065

Weill Cornell Medical College/ New York Presbyterian hospital, New York

All Listed Sponsors
lead

Weill Medical College of Cornell University

OTHER

NCT01581411 - Intra-arterial Thrombolysis for Severe Recent Central Retinal Vein Occlusion | Biotech Hunter | Biotech Hunter